source
- Benelux biotech strength hampered by fragmented investment, experts discuss path to unified corridorIn a recent episode of BioSpace's "Denatured" podcast, host Jennifer C. Smith-Parker talks with Christina Takke of V-Bio Ventures and Mariette van der Velden‑Roesink of Curie Capital about the biot…
- Novartis licenses Alteogen’s hyaluronidase enzyme ALT-B4 in new drug delivery partnershipNovartis announced a licensing agreement with South Korean biotech Alteogen to use its hyaluronidase enzyme ALT-B4 for drug delivery applications. The enzyme will be produced using Alteogen’s prop…